Anzaan Dippenaar

Anzaan Dippenaar is a mycobacteriology researcher at the Institute of Tropical Medicine Antwerp (ITG), Belgium, with a research focus on tuberculosis drug resistance mechanisms. Their work combines genomic approaches with clinical epidemiology to understand resistance patterns in Mycobacterium tuberculosis.

Research interests center on drug-resistant tuberculosis, particularly investigating resistance mechanisms to newer drugs like bedaquiline and pretomanid. Their work employs advanced genomic techniques including nanopore sequencing to analyze transmission patterns and resistance mutations across different M. tuberculosis lineages.

Recent publications demonstrate expertise in molecular epidemiology of drug-resistant TB, with significant contributions to understanding resistance mechanisms and transmission dynamics, particularly in high-burden settings like South Africa. Their research has been published in high-impact journals including Lancet Microbe and Journal of Antimicrobial Chemotherapy.

• Active collaboration with South African research institutions
• Specialization in genomic analysis of drug resistance
• Focus on newer anti-TB drugs and resistance mechanisms